Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-20-003295
Filing Date
2020-02-05
Accepted
2020-02-05 17:00:15
Documents
1
Period of Report
2017-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 2973
  Complete submission text file 0000899243-20-003295.txt   4298
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 505 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address
Machiels Alec (Reporting) CIK: 0001496687 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-38276 | Film No.: 20579581